EX-FILING FEES 3 tm2317619d1_ex-fillingfees.htm EX-FILING FEES

Exhibit 107

 

Calculation of Filing Fee Tables

 

S-1

(Form Type)

 

First Wave BioPharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type
  Security
Class Title
  Fee
Calculation
or Carry
Forward
Rule 
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering
Price(1) 
  Fee Rate   Amount of
Registration
Fee

Fees to Be

Paid

  Equity   Common Stock, par value $0.0001 per share (“Common Stock”)(2)       457(o)           $5,000,000   0.00011020   $551.00
    Other   Pre-funded Warrants to purchase Common Stock(3)       457(g)                 (3)(4)
    Equity   Common Stock underlying the Pre-Funded Warrants(3)       457(o)                 (3)
    Other   Warrants to purchase Common Stock       457(g)                 (4)
    Equity   Common Stock underlying the Warrants to purchase Common Stock       457(o)           $5,000,000   0.00011020   $551.00

Fees

Previously Paid

                     

Carry

Forward Securities

                         
    Total Offering Amounts       $10,000,000   0.00011020   $1,102.00
    Total Fees Previously Paid              
    Total Fee Offsets              
    Net Fee Due               $1,102.00

 

(1) Estimated solely for the purpose of calculating the amount of the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).
(2) Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant’s securities that become issuable by reason of any share splits, share dividends or similar transactions.
(3) The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Common Stock and pre-funded warrants (including the Common Stock issuable upon exercise of the pre-funded warrants), if any, is $5,000,000.
(4) No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.